Nerve Electrode with Drug Transfer Layer for Inflammation Suppression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nerve electrodes face challenges in suppressing inflammation when inserted into the body, which can lead to adverse reactions and reduce their effectiveness in rehabilitation and signal detection.
Innovation Solution
A nerve electrode design featuring a flexible substrate with separate linear and planar electrodes, an insulating layer, and a drug transfer layer made of nanofibers containing anti-inflammatory drugs like dexamethasone, sulindac, or tolmetin, along with a hydrogel layer and a PEDOT layer, which are manufactured using specific photolithography and electrospinning processes to minimize inflammation and optimize drug delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nerve electrodes are inserted into the body for long-term use, then rehabilitation and signal detection effectiveness is improved, but inflammation generation increases
Solution Approach 1:
The patent applies preliminary action by pre-coating the nerve electrode surface with anti-inflammatory drugs (dexamethasone, sulindac, or tolmetin) before implantation. The drugs are incorporated into a polymer matrix that controls their release over time, preventing inflammation from occurring in the first place rather than treating it after implantation. This preliminary drug delivery system ensures that the electrode surface is already protected when it contacts neural tissue.
Solution Approach 2:
The patent uses an intermediary approach by introducing a polymer-coated drug delivery layer between the metal electrode and the neural tissue. This intermediary layer acts as a buffer that mediates the interaction between the electrode and biological tissue, releasing anti-inflammatory drugs to suppress the harmful inflammatory response while allowing the electrode to perform its neurological functions.
2Object-affected harmful factors
If anti-inflammatory drugs are applied to nerve electrodes, then inflammation is suppressed, but device complexity increases
Solution Approach 1:
The patent merges the drug delivery function with the electrode structure itself by coating the anti-inflammatory drugs directly onto the electrode surface and forming an integrated polymer matrix. This combination eliminates the need for separate drug delivery devices or complex multi-component systems, as the therapeutic function is built directly into the electrode assembly.
Solution Approach 2:
The patent applies parameter changes by controlling the physical and chemical properties of the polymer coating and drug formulation to achieve controlled release kinetics. By adjusting parameters such as polymer composition, crosslinking density, and drug concentration, the system achieves sustained drug delivery without requiring complex mechanical or electronic control mechanisms.
3Object-affected harmful factors
If multiple layers (drug transfer layer, hydrogel layer, PEDOT layer) are added to the electrode, then drug delivery and inflammation suppression are improved, but manufacturing precision requirements increase
Solution Approach 1:
The patent replaces complex mechanical layering processes with electrochemical deposition methods. The PEDOT layer is formed through electropolymerization, and the drug-containing polymer matrix is deposited through electrospinning or electrophoretic deposition. These electrochemical methods provide inherent control over layer thickness and uniformity, reducing the need for precise mechanical positioning and multiple alignment steps.
Solution Approach 2:
The patent uses porous polymer matrices and hydrogel layers that can be formed through self-assembly or controlled phase separation during the coating process. These porous structures allow for drug incorporation and controlled release while being formed through processes that are more tolerant of manufacturing variations compared to dense, non-porous coatings that would require stricter precision control.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution effectively suppresses inflammation and ensures long-term anti-inflammatory effects by controlled drug release, maintaining the integrity of nerve electrodes and enhancing their rehabilitation and signal detection capabilities.
Implementation Method 1
The drug transfer layer may include nanofibers that are formed by electrospinning
Implementation Method 2
The nerve electrode may further include poly(3,4-ethylenedioxythiophene) (PEDOT) layer that is positioned on the linear electrode
Data Source
AI summary
A nerve electrode that is inserted into a living body and that is configured to attach to nerves is provided. The nerve electrode that is inserted into a living body and that is configured to attach to nerves includes: i) a flexible substrate; ii) a plurality of electrodes that are separately positioned on the flexible substrate; and iii) an insulating layer that is positioned at a separation space of the plurality of electrodes and that insulates the plurality of electrodes. The plurality of electrodes include i) at least one linear electrode, and ii) a planar electrode that is separated from the linear electrode. An anti-inflammatory drug transfer layer is positioned on the planar electrode.